...
首页> 外文期刊>Journal of Analytical Toxicology >Metabolic Patterns of Fentanyl, Meperidine, Methylphenidate, Tapentadol and Tramadol Observed in Urine, Serum or Plasma
【24h】

Metabolic Patterns of Fentanyl, Meperidine, Methylphenidate, Tapentadol and Tramadol Observed in Urine, Serum or Plasma

机译:在尿液,血清或血浆中观察到芬太尼,哌替啶,甲基酚,塔布多尔和曲马多的代谢模式

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Drug testing is a useful tool to identify drug use or monitor adherence to prescription drugs. The interpretation of drug results can be complicated based on the pattern and proportional concentrations of drugs and/or drug metabolite(s). The purpose of this retrospective study was to detect the positivity rates and metabolic patterns of five prescription drugs, including fentanyl, meperidine, methylphenidate, tapentadol and tramadol. Retrospective data were retrieved from the laboratory information system in a national reference laboratory. Drug testing was performed using four mass spectrometry methods that were validated for clinical use. For urine specimens, the positivity rate was the highest for methylphenidate (62.3%, n = 2,489), followed by tramadol (43.7%, n = 3,483), fentanyl (41.9%, n = 4,657), tapentadol (37.9%, n = 736) and meperidine (8.3%, n = 138). Among positive samples, both parent drug and metabolite(s) was detectable in 94.9% of meperidine samples, 94.5% of tramadol samples, 93.8% of fentanyl samples, 89.9% of methylphenidate and 86.6% of tapentadol samples. For serum or plasma specimens, the positivity rate was the highest for tapentadol (75.0%, n = 39), followed by methylphenidate (74.2%, n = 569), fentanyl (53.6%, n = 113), meperidine (41.9%, n = 18) and tramadol (28.9%, n = 213). Similar metabolic patterns were found in serum or plasma. Of positive results, both parent drug and metabolite(s) were found in 94.7% of fentanyl samples, 83.3% of meperidine samples, 79.6% of methylphenidate samples, 53.8% of tapentadol samples and 44.1% of tramadol samples. Our data demonstrates the metabolic patterns of five drugs from a random urine or serum/plasma collection in patients that have been prescribed these medications. The data presented can be used to guide clinicians in determining drug adherence by assessing the positivity rates of the parent drug and corresponding metabolite(s).
机译:药物测试是一种识别药物使用或监测对处方药的粘附的有用工具。药物结果的解释可以根据药物和/或药物代谢物的模式和比例浓度复杂化。该回顾性研究的目的是检测五种处方药的阳性率和代谢模式,包括芬太尼,哌替啶,甲基酚,鸟蛋白和曲马多。从国家参考实验室的实验室信息系统中检索回顾性数据。使用四种质谱法进行药物检测,该方法验证了临床用途。对于尿标本,亚甲基酚的阳性率最高(62.3%,n = 2,489),其次是曲马多(43.7%,n = 3,483),芬太尼(41.9%,n = 4,657),塔伯纳多尔(37.9%,n = 736)和Meperidine(8.3%,n = 138)。在阳性样品中,母体药物和代谢物均可在94.9%的哌啶样品中检测,94.5%的曲马多样,93.8%的芬太尼样品,89.9%的甲基苯二甲酸酯和86.6%的Tabentadol样品。对于血清或血浆标本,菌丝蛋白的阳性率最高(75.0%,n = 39),其次是甲基酚(74.2%,n = 569),芬太尼(53.6%,n = 113),哌啶(41.9%, n = 18)和曲马多(28.9%,n = 213)。在血清或血浆中发现了类似的代谢模式。阳性结果,在94.7%的芬太尼样品中发现母体药物和代谢物,近哌啶样品的83.3%,甲基酚素样品的79.6%,塔巴替尔样品的53.8%和44.1%的曲马多样。我们的数据显示出从患者中出售这些药物的患者的随机尿或血清/等离子体收集中的五种药物的代谢模式。所提出的数据可用于通过评估母体药物和相应的代谢物的阳性率来指导临床医生确定药物粘附。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号